Jonas Demeulemeester
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
Papers in
- Virology 31
- HIV Research and Treatment 31
-
- HIV/AIDS drug development and treatment 28
- Co-authors
- Zeger DebyserFrauke ChristRik GijsbersJan De RijckSofie VetsRik SchrijversBelete A. DesimmieSara El Ashkar
- Journals
- Retrovirology (5 papers)Journal of Biological Chemistry (4 papers)Nature Communications (3 papers)Cell Reports (2 papers)Drug Discovery Today Technologies (2 papers)
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
Jonas Demeulemeester
57 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 89
- Virology 837
- Infectious Diseases 709
- Aging 35
- Molecular Biology 1.1k
- Genetics 250
Countries citing papers authored by Jonas Demeulemeester
This map shows the geographic impact of Jonas Demeulemeester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Demeulemeester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Demeulemeester more than expected).
Fields of papers citing papers by Jonas Demeulemeester
This network shows the impact of papers produced by Jonas Demeulemeester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Demeulemeester. The network helps show where Jonas Demeulemeester may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonas Demeulemeester, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 30 | |
| 3 | 2023 | 12 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 18 | |
| 6 | 2021 | 42 | |
| 7 | 2021 | 14 | |
| 8 | 2018 | 26 | |
| 9 | 2016 | 18 | |
| 10 | 2015 | 56 | |
| 11 | 2015 | 49 | |
| 12 | 2014 | 42 | |
| 13 | 2014 | 22 | |
| 14 | 2014 | 34 | |
| 15 | 2014 | 9 | |
| 16 | 2013 | 11 | |
| 17 | 2012 | 24 | |
| 18 | 2012 | 24 | |
| 19 | 2012 | 11 | |
| 20 | 2012 | 31 |
About Jonas Demeulemeester
Jonas Demeulemeester is a scholar working on Virology, Infectious Diseases, Aging, Molecular Biology and Cancer Research, having authored 59 papers that have together received 1.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (31 papers), HIV/AIDS drug development and treatment (28 papers), Biochemical and Molecular Research (7 papers), Cancer Genomics and Diagnostics (7 papers), Nuclear Structure and Function (6 papers), Virus-based gene therapy research (5 papers), CRISPR and Genetic Engineering (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Virology (837 citations), Infectious Diseases (709 citations), Aging (35 citations), Molecular Biology (1.1k citations) and Genetics (250 citations). Jonas Demeulemeester has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Zeger Debyser, Frauke Christ, Rik Gijsbers, Jan De Rijck, Sofie Vets, Rik Schrijvers, Belete A. Desimmie, Sara El Ashkar, Arnaud Marchand and Patrick Chaltin. Their work appears in journals such as Retrovirology, Journal of Biological Chemistry, Nature Communications, Cell Reports and Drug Discovery Today Technologies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.